about
Sequence-Based analysis of the HLA-DRB1 polymorphism in Metalsa Berber and Chaouya Arabic-speaking groups from MoroccoHuman leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typingTotal IL-12 levels are increased in paediatric atopic dermatitis: correlations with age and disease severity.The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy.MICA∗078: A novel allele identified in a Moroccan individual affected by celiac disease.Gender-specific cytokine pathways, targets, and biomarkers for the switch from health to adenoma and colorectal cancer.CD1A, D and E gene polymorphisms in a North African population from Morocco.A gender-related action of IFNbeta-therapy was found in multiple sclerosis.Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age.Increased CD1D polymorphism: identification of two novel alleles, CD1D*03 and *04, in individuals from Morocco.Correlation between genetic HLA class I and II polymorphisms and anthropological aspects in the Chaouya population from Morocco (Arabic speaking).Sequence-based typing characterization of the novel HLA-Cw*1609 allele in the Moroccan Chaouya group.Involvement of IL-6 and IL-1 receptor antagonist on intellectual disability.A new HLA-CW*14 allele, Cw*140204, identified by allele-specific DNA amplification and sequencing.Identification of the novel allele B*4427 and a confirmatory sequence (B*44022).Sequence analysis of a new HLA-DR11 allele in a Caucasian Italian family: DRB1*11272.HLA-DRB1*13:01 allele in the genetic susceptibility to colorectal carcinoma.Attention-deficit hyperactivity disorder and intellectual disability: a study of association with brain-derived neurotrophic factor gene polymorphisms.The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender- specific Biomarkers in Personalized Cancer Therapy.Investigation on the possible relationship existing between the HLA-DR gene and attention deficit hyperactivity disorder and/or mental retardation.Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network.Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients.Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy.Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progressionProgression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlationsCytokine contribution to the repair processes and homeostasis recovery following anoxic insult: a possible IFN-gamma-regulating role in IL-1beta neurotoxic action in physiological or damaged CNSHLA class I residue mismatch and renal graft outcomeDisease stage prognostic indices in the early clinical screening of colorectal cancer patientsThe sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancerIL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancerImmunological implications of alterations in the c-Ki-ras and p53 genes in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understandingPrognostic significance of immunological evaluation in colorectal cancerNecessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancerImmunological directives for biotherapy improvement in the treatment of colorectal cancerThe significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and backThe role of beta-pleated sheet DRB1 differences in acute rejection after cadaveric renal transplantPeripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancerThe study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancerAre immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement?
P50
Q28217020-31C484E2-ED23-4F9F-B2C2-7880F5CF1198Q28237088-21F73537-82D5-426C-B394-93966F521173Q33343130-23FEF699-FC73-4B5D-8622-252E43D8AA4BQ35222365-B5D555B7-9F31-471E-9B11-292C53A76F0AQ35583340-8B496159-640A-4F20-9A4B-DAC1170B75A3Q35659961-76394622-7312-4A45-A9A1-5EC63C111473Q36011642-33DABF3E-08D7-401D-90B8-48D7B00D1BDEQ36594388-415A52E7-1C15-4A92-9A8C-490B5A0972F1Q37171499-F0181D10-0B09-46B8-89D9-7670854D1D89Q37581323-374A5598-9676-49CB-B1AF-6AF9C3DE2CA2Q38884023-39FE0D4D-0AE2-4A4A-BD19-2F97349186B1Q38931031-7CE4419B-576C-44C4-AE13-2A28D49FB750Q38931034-EBBE1AC5-08F0-491D-A6C6-846C283BCA19Q44047432-C3A149CB-0380-4AEF-A9FA-C0C60C401617Q48086745-2AF57590-8321-4F94-AC59-DA540F6FDE91Q48292167-75A867A2-97B2-416E-A34B-5035D79F8448Q48386468-3DC0CB63-65A9-44D1-B823-EB5F4D62FC11Q48820164-C7818CB6-BC2E-4948-B8EE-F8F6BA406052Q51034231-0697715F-3263-40AF-9C9B-E87B97CF6698Q51651751-72C3DC99-8B6A-4FD9-A685-C8D2C1CD3460Q51873257-68C57D8D-0D13-43F3-A476-D9D0A5D1EF4CQ52077578-962BAE3D-F2D5-48A3-985D-354710142F2DQ52599699-E58D599B-ACED-4EA1-8DBD-BADB8418B79BQ53340003-F894F1CB-2C93-49CB-A086-C1C9A008FCFFQ71067755-33CE9356-0A87-4E38-8454-0694EBD95B3FQ72670663-4FB803D5-9C15-4856-875A-E2F5FAA0D1AEQ73204913-355391BD-09A7-4967-8321-318ECD17200EQ73286067-06AF50BD-53A9-4C08-9F07-2E5599C9B91BQ73886731-3A4E9A9C-C76A-450C-B5E9-CDE855E715CDQ73889975-F3105B7F-24FA-40D5-93F9-110D29B2D352Q73889980-E9A76BEE-5F23-4CFF-9C5E-CF4CFEBF60D8Q73890072-D476DD7D-F47F-4370-890A-D15C1CE8C058Q73890091-A0D6AC95-E4E5-4864-9AFC-8E3B5D2580E2Q73890097-6B74A0CC-68E5-49D0-BCB7-72DB76FFEC9EQ73890189-E57A5E14-FCE3-4D33-AA95-B8F15258B591Q74079410-B5FE2D35-0A3E-4D93-858C-793270EB6E7BQ74616626-C4D4C191-FBF1-4B5B-A0B5-B5D4B1E976FAQ77823994-835759DA-E143-485E-B660-3AF6E8492A72Q79359133-FABA35C4-5AED-4C9A-851C-04DD2B034054Q79359135-0EEF4E50-641E-427E-9EAD-A66FE1578986
P50
description
researcher
@en
wetenschapper
@nl
name
T Del Beato
@en
T Del Beato
@nl
type
label
T Del Beato
@en
T Del Beato
@nl
prefLabel
T Del Beato
@en
T Del Beato
@nl
P106
P31
P496
0000-0002-8559-7023